JWA
AGIO icon

JFS Wealth Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

JFS Wealth Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75 Hold
2
– – ﹤0.01% 2223
2026
Q1 		$68 Sell
2
-2
-50% -$57 ﹤0.01% 1856
2025
Q4 		$109 Sell
4
-12
-75% -$421 ﹤0.01% 1883
2025
Q3 		$643 Hold
16
– – ﹤0.01% 1717
2025
Q2 		$533 Buy
16
+11
+220% +$333 ﹤0.01% 1687
2025
Q1 		$147 Sell
5
-10
-67% -$332 ﹤0.01% 1854
2024
Q4 		$493 Hold
15
– – ﹤0.01% 1777
2024
Q3 		$667 Buy
15
+11
+275% +$500 ﹤0.01% 1759
2024
Q2 		$173 Hold
4
– – ﹤0.01% 1903
2024
Q1 		$117 Hold
4
– – ﹤0.01% 1936
2023
Q4 		$90 Sell
4
-3
-43% -$67 ﹤0.01% 1957
2023
Q3 		$174 Buy
7
+1
+17% +$26 ﹤0.01% 1876
2023
Q2 		$170 Hold
6
– – ﹤0.01% 1894
2023
Q1 		$138 Sell
6
-2
-25% -$53 ﹤0.01% 1863
2022
Q4 		$225 Hold
8
– – ﹤0.01% 1823
2022
Q3 		$0 Buy
8
+4
+100% +$107 ﹤0.01% 1716
2022
Q2 		$0 Sell
4
-2
-33% -$45 ﹤0.01% 1713
2022
Q1 		$0 Buy
6
+4
+200% +$122 ﹤0.01% 1804
2021
Q4 		$0 Buy
+2
New +$81 ﹤0.01% 1690

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

JFS Wealth Advisors's AGIO Position: Q2 2026 in Review

JFS Wealth Advisors held its Agios Pharmaceuticals (AGIO) position steady in Q2 2026 at 2 shares worth $75. The position accounts for ﹤0.01% of the portfolio, ranked #2223.

JFS Wealth Advisors first reported a position in AGIO in Q4 2021 and has held it in 19 quarters since. The position peaked at $667 in Q3 2024. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • JFS Wealth Advisors held 2 shares of Agios Pharmaceuticals worth $75 as of Q2 2026.
  • JFS Wealth Advisors left its Agios Pharmaceuticals share count unchanged in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #2223 holding.
  • JFS Wealth Advisors first reported a position in Agios Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • JFS Wealth Advisors's Agios Pharmaceuticals position peaked at $667 in Q3 2024.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.